A bold vision for Australia's healthcare future is taking shape, with leading genomic researchers advocating for a national DNA screening program. The potential benefits are immense, but the path forward is not without its challenges and controversies.
The Case for a National DNA Screening Program
Researchers from Monash University's DNA Screen program argue that such an initiative could revolutionize public health in Australia. Their pilot program, which tested the DNA of 10,000 Australians aged 18-40, revealed that 2% of participants carried high-risk genetic variants for hereditary breast and ovarian cancer, Lynch syndrome, or familial hypercholesterolemia (FH).
Currently, publicly funded DNA testing in Australia is limited to a small cohort meeting strict eligibility criteria. However, the researchers estimate that around nine in ten Australians at high risk of adult-onset genomic conditions remain undetected.
The Role of GPs
Professor Mark Morgan, Chair of the RACGP Expert Committee on Quality Care, believes GPs will play a crucial role in any future DNA screening program. He argues that existing programs miss the optimum time to initiate active surveillance and risk-reduction measures.
"There is widespread under-detection of FH, Lynch syndrome, and hereditary breast and ovarian cancer," Professor Morgan says. "Our current approach of relying on family history and cascade testing of relatives is not sufficient. Genetic tests may soon offer a more accurate way to assess risk."
International Precedents
Australia is not alone in recognizing the potential of DNA screening. The United Kingdom is already developing the infrastructure for national DNA testing through its National Health Service. By 2030, every newborn baby in England will have their DNA mapped, aiming to predict and prevent diseases and ease the burden on healthcare services.
Singapore is also actively rolling out public DNA screening. In November, it launched phase 3 of its National Precision Medicine program, aiming to collect genetic data from up to 450,000 patients by 2031.
The Demand for Public Screening
The response to Monash University's pilot program was overwhelming, with over 30,000 people registering for the 10,000 funded spots. This indicates a strong desire among young Australians with high genetic risk to access public screening.
"Most of the participants would not have qualified for existing government-funded genomic testing," says Professor Paul Lacaze, Head of Public Health Genomics at Monash and lead of the DNA Screen project. "Identifying people early, before disease develops, allows us to intervene, save lives, and reduce future healthcare costs."
Addressing Challenges and Controversies
Professor Morgan highlights the importance of ensuring the program is accessible to all, not just highly motivated individuals in urban centers. He also raises questions about the long-term availability of results and gaining consent for future tests without recollecting specimens.
"I envision a future where a single genetic test is carefully utilized to guide numerous healthcare interventions," he says.
The researchers are now seeking $50 million from the Federal Government to fund the next phase of their program, which will involve 100,000 participants and help shape the implementation of a national DNA screening initiative.
What are your thoughts on the potential of DNA screening? Do you think Australia should follow the lead of other nations in implementing such a program? Share your opinions and join the conversation below!
